Phenotypic characteristics of human type II alveolar epithelial cells suitable for antigen presentation to T lymphocytes.
BACKGROUND
Type II alveolar epithelial cells (AECII) are well known for their role in the innate immune system. More recently, it was proposed that they could play a role in the antigen presentation to T lymphocytes but contradictory results have been published both concerning their surface expressed molecules and the T lymphocyte responses in mixed lymphocyte cultures. The use of either AECII cell line or fresh cells could explain the observed discrepancies. Thus, this study aimed at defining the most relevant model of accessory antigen presenting cells by carefully comparing the two models for their expression of surface molecules necessary for efficient antigen presentation.


METHODS
We have compared by flow cytometry the surface expression of the major markers involved in the immunological synapse on the A549 cell line, the most popular model of type II alveolar epithelial cells, and freshly isolated cells. HLA-DR, CD80, CD86, ICOS-L, CD54, CD58 surface expression were studied in resting conditions as well as after IFN-γ/TNF-α treatment, two inflammatory cytokines, known to modulate some of these markers.


RESULTS
The major difference found between the two cells types was the very low surface expression of HLA-DR on the A549 cell line compared to its constitutive expression on freshly isolated AECII. The surface expression of co-stimulatory molecules from the B7 family was very low for the CD86 (B7-2) and ICOS-L (B7-H2) and absent for CD80 (B7-1) on both freshly isolated cells and A549 cell line. Neither IFN-γ nor TNF-α could increase the expression of these classical co-stimulatory molecules. However CD54 (ICAM-1) and CD58 (LFA-3) adhesion molecules, known to be implicated in B7 independent co-stimulatory signals, were well expressed on the two cell types.


CONCLUSIONS
Constitutive expression of MHC class I and II molecules as well as alternative co-stimulatory molecules by freshly isolated AECII render these cells a good model to study antigen presentation.
Laboratory of Vaccinology and Mucosal Immunity, Université Libre de Bruxelles (U,L,B,), Brussels, Belgium.
Véronique
V
Corbière
Violette
V
Dirix
Sarah
S
Norrenberg
Mattéo
M
Cappello
Myriam
M
Remmelink
Françoise
F
Mascart
D056809:Alveolar Epithelial Cells / Q000276:immunology*; D017951:Antigen Presentation; D000938:Antigen-Presenting Cells / Q000276:immunology*; D015703:Antigens, CD / Q000378:metabolism*; D045744:Cell Line, Tumor; D002478:Cells, Cultured; D005434:Flow Cytometry; D006684:HLA-DR Antigens / Q000378:metabolism*; D006801:Humans; D016130:Immunophenotyping / Q000379:methods; D018836:Inflammation Mediators / Q000378:metabolism; D007371:Interferon-gamma / Q000378:metabolism; D010641:Phenotype; D013601:T-Lymphocytes / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D015703:Antigens, CD; D006684:HLA-DR Antigens; D018836:Inflammation Mediators; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma
Am J Physiol Lung Cell Mol Physiol. 2005 Aug;289(2):L274-9
15833765
J Immunol. 2001 Jun 15;166(12):7300-8
11390480
J Immunol. 1992 Apr 1;148(7):1985-92
1372018
Immunology. 1995 Oct;86(2):279-86
7490130
Virus Res. 2008 Apr;133(1):4-12
17825937
Placenta. 1991 May-Jun;12(3):217-26
1754572
Am J Respir Cell Mol Biol. 2004 Apr;30(4):500-9
15033639
Eur J Immunogenet. 1998 Dec;25(6):385-91
9949943
Arch Biochem Biophys. 2004 May 15;425(2):147-57
15111122
Immunol Rev. 1996 Oct;153:47-83
9010719
J Immunol. 2008 Jan 15;180(2):881-8
18178827
J Cell Sci. 1994 Feb;107 ( Pt 2):443-9
8207072
Am J Respir Cell Mol Biol. 1999 Sep;21(3):365-79
10460754
Immunology. 1997 Jul;91(3):458-63
9301537
Infect Immun. 1996 Jul;64(7):2673-9
8698494
Am J Pathol. 2004 Mar;164(3):861-71
14982840
Microbes Infect. 2004 Jan;6(1):129-39
14738901
Respir Res. 2001;2(1):33-46
11686863
Behring Inst Mitt. 1993 Dec;(93):224-35
8172571
Infect Immun. 1998 Mar;66(3):1121-6
9488404
Lancet. 2000 Dec 23-30;356(9248):2133-8
11191539
Proc Am Thorac Soc. 2008 Sep 15;5(7):778-82
18757317
Clin Exp Allergy. 1998 Jan;28(1):10-8
9537771
Eur J Immunol. 2006 Apr;36(4):906-18
16552709
Infect Immun. 1996 Apr;64(4):1400-6
8606107
Eur J Immunol. 1996 Jun;26(6):1273-7
8647204
Am J Physiol Lung Cell Mol Physiol. 2004 Aug;287(2):L318-31
15246982
Jpn J Infect Dis. 2010 Jan;63(1):67-71
20093768
Cell Microbiol. 2008 Apr;10(4):945-57
18067609
Am J Respir Crit Care Med. 2009 Mar 1;179(5):344-55
19096007
Int J Cancer. 1976 Jan 15;17(1):62-70
175022
J Immunol. 2000 Dec 1;165(11):6091-8
11086041
Scand J Immunol. 1988 Sep;28(3):351-7
3143150
Cell Mol Life Sci. 1998 Sep;54(9):965-78
9791539
Microbiol Immunol. 2005;49(10):885-90
16237265
Infect Immun. 2002 Jan;70(1):140-6
11748175